Inmune Bio, Inc. Files 8-K: Accountant Change & Exhibits
Ticker: INMB · Form: 8-K · Filed: May 7, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, filing
Related Tickers: INMB
TL;DR
Inmune Bio changed auditors, filed exhibits. No major news yet.
AI Summary
On May 7, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns changes in the registrant's certifying accountant and includes financial statements and exhibits. No specific financial figures or new business developments were detailed in the provided excerpt.
Why It Matters
This filing indicates a change in Inmune Bio's auditor, which could signal internal changes or a need for a fresh perspective on financial reporting.
Risk Assessment
Risk Level: low — The filing is procedural, detailing changes in auditors and the submission of exhibits, with no immediate negative or positive financial implications presented.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- May 7, 2025 (date) — Date of earliest event reported
FAQ
What is the specific reason for the change in Inmune Bio, Inc.'s certifying accountant?
The provided excerpt does not specify the reason for the change in the certifying accountant.
When was the change in the certifying accountant effective?
The filing indicates the date of change as May 7, 2025.
What are the key financial statements and exhibits included in this filing?
The excerpt states that financial statements and exhibits are included, but does not list their specific contents.
What is Inmune Bio, Inc.'s principal executive office address?
Inmune Bio, Inc.'s principal executive offices are located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
What is Inmune Bio, Inc.'s telephone number?
Inmune Bio, Inc.'s telephone number is (561) 710-0512.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Inmune Bio, Inc. (INMB).